NuGen Medical Devices Third Quarter 2023 Earnings: CA$0.012 loss per share (vs CA$0.012 loss in 3Q 2022)

NuGen Medical Devices (CVE:NGMD) Third Quarter 2023 Results

Key Financial Results

• Net loss: CA$2.28m (loss widened by 105% from 3Q 2022).
• CA$0.012 loss per share (in line with 3Q 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

NuGen Medical Devices shares are up 4.5% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 7 warning signs for NuGen Medical Devices (5 are significant) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.